EX-32 4 appy_10q-ex32.htm CERTIFICATION appy_10q-ex32.htm

 
 
EXHIBIT 32
 
 
TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
 
 
        In connection with the Quarterly Report on Form 10-Q (the “Report”) of AspenBio Pharma, Inc. (the “Company”) for the quarter ended September 30, 2009, each of the undersigned Daryl J. Faulkner and Jeffrey G. McGonegal, hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of the undersigned’s knowledge and belief:
 
 
(1)
the Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 
(2)
the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

     
November 5, 2009
    
 
/s/ Daryl J. Faulkner
  
 
Daryl J. Faulkner,
Chief Executive Officer, Executive Chairman and Director
  
     

 
     
November 5, 2009
    
 
/s/ Jeffrey G. McGonegal
  
 
Jeffrey G. McGonegal,
Chief Financial Officer
  
     



 
*  *  *  *  *